ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

TJX pre-market earnings eyed as shares trade near 52-week high

Second-quarter fiscal 2027 results expected to show 8.2% EPS growth and 5.5% revenue rise, with consensus target implying 17.6% upside from Tuesday’s close.

PA
Priya Anand · Equities & Earnings Desk · 19 Aug 2026 · 08:26 · 1 min read
Share
TJX pre-market earnings eyed as shares trade near 52-week high

TJX Companies Inc. is set to report second-quarter fiscal 2027 results before the market opens on Wednesday, with analysts anticipating an 8.2% increase in earnings per share to $1.19 and a 5.5% rise in revenue to $15.19 billion.

The off-price retailer’s shares closed Tuesday at $150.85, trading 11% below a 52-week high of $170 and near a consensus price target of $177.40, which implies a 17.6% upside. Analysts at Morgan Stanley maintain an overweight rating with a $181 target, while the broader consensus among 22 analysts shows 20 rating the stock a buy.

First-quarter results, reported in May, exceeded expectations with EPS of $1.19 versus a $1.02 consensus and revenue of $14.3 billion, topping forecasts by 2.14%. For the full fiscal year, TJX projects pre-tax margins of approximately 12% and EPS between $5.08 and $5.15.

Valuation metrics remain elevated, with trailing and forward earnings multiples of 28.78x and 28.98x, respectively. Over the past two months, EPS estimates have edged down by 0.15%, while revenue estimates have held steady. The global off-price retail market is projected to expand from $349.22 billion in 2025 to $582.14 billion by 2031, driven by sustained consumer demand for budget-friendly shopping amid inflation and economic uncertainty.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT